Guilherme Rodrigues Fernandes Campos
Overview
Explore the profile of Guilherme Rodrigues Fernandes Campos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moraes M, Campos G, Banho C, Versiani A, Lopes Dos Santos T, Parra M, et al.
Pathogens
. 2025 Jan;
13(12.
PMID: 39770329
During the COVID-19 pandemic, SARS-CoV-2 caused an alarming number of cases and deaths worldwide. Brazil was severely affected from late 2020 onward, especially after the emergence of variants of concern...
2.
Corsini C, Martins P, Filgueiras P, Lourenco A, Lima A, Gomes S, et al.
Res Sq
. 2024 Mar;
PMID: 38464059
Introduction: Vaccines are essential for the prevention and control of several diseases, indeed, monitoring the immune response generated by vaccines is crucial. The immune response generated by vaccination against SARS-CoV-2...
3.
Gomes da Costa V, Gomes A, Bittar C, Geraldini D, da Conceicao P, Cabral A, et al.
Viruses
. 2023 Mar;
15(3).
PMID: 36992374
Non-SARS-CoV-2 respiratory viral infections, such as influenza virus (FluV) and human respiratory syncytial virus (RSV), have contributed considerably to the burden of infectious diseases in the non-COVID-19 era. While the...
4.
Rodrigues J, Campos G, Bittar C, Martinelli A, Campos M, Pereira L, et al.
Braz J Infect Dis
. 2022 Nov;
26(6):102717.
PMID: 36410397
The chronic hepatitis C (CHC) treatment is currently based on the use of direct-acting antivirals (DAAs), and patients infected with hepatitis C virus genotype 3 (GT3) have emerged as a...
5.
Banho C, Sacchetto L, Campos G, Bittar C, Possebon F, Ullmann L, et al.
Commun Med (Lond)
. 2022 May;
2:41.
PMID: 35603276
Background: The emergence of the Brazilian variant of concern, Gamma lineage (P.1), impacted the epidemiological profile of COVID-19 cases due to its higher transmissibility rate and immune evasion ability. Methods:...
6.
Campos G, Ward J, Chen S, Bittar C, Rodrigues J, Martinelli A, et al.
J Gen Virol
. 2021 Mar;
102(3).
PMID: 33787486
No abstract available.
7.
Campos G, Ward J, Chen S, Bittar C, Rodrigues J, Martinelli A, et al.
J Gen Virol
. 2020 Nov;
102(1).
PMID: 33141008
Hepatitis C virus (HCV) genotype 3 presents a high level of both baseline and acquired resistance to direct-acting antivirals (DAAs), particularly those targeting the NS5A protein. To understand this resistance...
8.
Ward J, Bowyer S, Chen S, Campos G, Ramirez S, Bukh J, et al.
J Gen Virol
. 2020 Sep;
101(11):1182-1190.
PMID: 32897181
Hepatitis C virus (HCV) is an important human pathogen causing 400 000 chronic liver disease-related deaths annually. Until recently, the majority of laboratory-based investigations into the biology of HCV have...
9.
Aguiar B, Campos G, Rodrigues J, Marques N, Molina B, Bittar C, et al.
Clin Res Hepatol Gastroenterol
. 2019 Sep;
44(3):329-339.
PMID: 31523019
Background: The World Health Organization estimates that 1% of the world population (71 million) is infected with hepatitis C virus (HCV). In 2015, three direct-acting antivirals (DAAs), simeprevir (SMV), sofosbuvir...
10.
Batista M, Braga A, Campos G, Souza M, de Matos R, Lopes T, et al.
Viruses
. 2019 Jan;
11(1).
PMID: 30641880
Zika virus (ZIKV) has been associated with serious health conditions, and an intense search to discover different ways to prevent and treat ZIKV infection is underway. Berberine and emodin possess...